Ultralife (NASDAQ:ULBI) Upgraded at StockNews.com

StockNews.com upgraded shares of Ultralife (NASDAQ:ULBI) from a buy rating to a strong-buy rating in a research note released on Monday morning.

Separately, Benchmark increased their target price on Ultralife from $13.00 to $14.00 and gave the company a buy rating in a research note on Thursday, June 27th.

Ultralife Trading Down 1.7 %

Ultralife stock opened at $10.12 on Monday. The stock has a market cap of $168.21 million, a P/E ratio of 15.81 and a beta of 0.99. Ultralife has a fifty-two week low of $6.36 and a fifty-two week high of $13.39. The firm’s fifty day moving average price is $10.64 and its 200-day moving average price is $10.05. The company has a debt-to-equity ratio of 0.07, a quick ratio of 2.06 and a current ratio of 4.07.

Ultralife (NASDAQ:ULBI) last released its quarterly earnings results on Thursday, July 25th. The technology company reported $0.22 earnings per share for the quarter, topping the consensus estimate of $0.14 by $0.08. The firm had revenue of $42.98 million for the quarter. Ultralife had a net margin of 5.96% and a return on equity of 9.32%.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in ULBI. Victory Capital Management Inc. bought a new position in Ultralife in the fourth quarter valued at $59,000. O Shaughnessy Asset Management LLC bought a new position in shares of Ultralife during the first quarter valued at about $100,000. Pitti Group Wealth Management LLC grew its stake in shares of Ultralife by 41.3% during the fourth quarter. Pitti Group Wealth Management LLC now owns 18,120 shares of the technology company’s stock valued at $124,000 after buying an additional 5,300 shares during the last quarter. Rhumbline Advisers grew its stake in shares of Ultralife by 1,728.3% during the second quarter. Rhumbline Advisers now owns 11,811 shares of the technology company’s stock valued at $125,000 after buying an additional 11,165 shares during the last quarter. Finally, Perritt Capital Management Inc. grew its stake in shares of Ultralife by 25.0% during the first quarter. Perritt Capital Management Inc. now owns 15,000 shares of the technology company’s stock valued at $132,000 after buying an additional 3,000 shares during the last quarter. Institutional investors own 30.68% of the company’s stock.

About Ultralife

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.